The US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component ...
Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.
the Hip business of Zimmer Biomet is projected to grow 2.6% in the first quarter on a year-over-year basis. Within the Knee business, apart from a strong recovery in elective procedures ...